Tissue Regenix Group plc (AIM:TRX)

Tissue Regenix Group Statistics

Total Valuation

AIM:TRX has a market cap or net worth of GBP 5.16 million. The enterprise value is 11.87 million.

Market Cap	5.16M
Enterprise Value	11.87M

Important Dates

The next estimated earnings date is Thursday, December 11, 2025.

Earnings Date	Dec 11, 2025
Ex-Dividend Date	n/a

Share Statistics

AIM:TRX has 71.23 million shares outstanding. The number of shares has increased by 1.29% in one year.

Current Share Class	71.23M
Shares Outstanding	71.23M
Shares Change (YoY)	+1.29%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	23.11%
Owned by Institutions (%)	64.79%
Float	45.93M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.25
PB Ratio	0.25
P/TBV Ratio	0.54
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 27.60, with an EV/FCF ratio of -4.59.

EV / Earnings	-11.90
EV / Sales	0.59
EV / EBITDA	27.60
EV / EBIT	n/a
EV / FCF	-4.59

Financial Position

The company has a current ratio of 2.88, with a Debt / Equity ratio of 0.38.

Current Ratio	2.88
Quick Ratio	0.67
Debt / Equity	0.38
Debt / EBITDA	18.67
Debt / FCF	-3.10
Interest Coverage	-0.44

Financial Efficiency

Return on equity (ROE) is -4.94% and return on invested capital (ROIC) is -0.73%.

Return on Equity (ROE)	-4.94%
Return on Assets (ROA)	-0.63%
Return on Invested Capital (ROIC)	-0.73%
Return on Capital Employed (ROCE)	-1.18%
Revenue Per Employee	220,184
Profits Per Employee	-10,837
Employee Count	92
Asset Turnover	0.60
Inventory Turnover	1.11

Taxes

Income Tax	-63,501
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -86.70% in the last 52 weeks. The beta is 0.79, so AIM:TRX's price volatility has been lower than the market average.

Beta (5Y)	0.79
52-Week Price Change	-86.70%
50-Day Moving Average	18.06
200-Day Moving Average	33.09
Relative Strength Index (RSI)	12.03
Average Volume (20 Days)	540,718

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, AIM:TRX had revenue of GBP 20.26 million and -997,043 in losses. Loss per share was -0.01.

Revenue	20.26M
Gross Profit	8.30M
Operating Income	-338,674
Pretax Income	-1.11M
Net Income	-997,043
EBITDA	377,358
EBIT	-338,674
Loss Per Share	-0.01

Balance Sheet

The company has 784,643 in cash and 8.03 million in debt, giving a net cash position of -7.24 million or -0.10 per share.

Cash & Cash Equivalents	784,643
Total Debt	8.03M
Net Cash	-7.24M
Net Cash Per Share	-0.10
Equity (Book Value)	20.89M
Book Value Per Share	0.30
Working Capital	10.86M

Cash Flow

In the last 12 months, operating cash flow was -332,105 and capital expenditures -2.25 million, giving a free cash flow of -2.59 million.

Operating Cash Flow	-332,105
Capital Expenditures	-2.25M
Free Cash Flow	-2.59M
FCF Per Share	-0.04

Margins

Gross margin is 40.98%, with operating and profit margins of -1.67% and -4.92%.

Gross Margin	40.98%
Operating Margin	-1.67%
Pretax Margin	-5.47%
Profit Margin	-4.92%
EBITDA Margin	1.86%
EBIT Margin	-1.67%
FCF Margin	n/a

Dividends & Yields

AIM:TRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.29%
Shareholder Yield	-1.29%
Earnings Yield	-19.31%
FCF Yield	-50.07%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 28, 2023. It was a reverse split with a ratio of 0.01.

Last Split Date	Apr 28, 2023
Split Type	Reverse
Split Ratio	0.01

Scores

AIM:TRX has an Altman Z-Score of -1.24 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.24
Piotroski F-Score	1